<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03697213</url>
  </required_header>
  <id_info>
    <org_study_id>18/0253</org_study_id>
    <nct_id>NCT03697213</nct_id>
  </id_info>
  <brief_title>The Surprise Study</brief_title>
  <official_title>An Online International Comparison of Thresholds for Triggering a Negative Response to the &quot;Surprise Question&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Johannes Gutenberg University Mainz</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Bern</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Imperial College London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Universiteit Antwerpen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Bologna</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University College, London</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the use of the Surprise Question [SQ] (would you be surprised if this
      patient were to die in the next 12 months?) in routine practice. In particular, the study
      will investigate the consistency of the responses to the SQ and the relationship with the
      subsequent course of action decided upon.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Whilst the original use of the Surprise Question was to identify people who might be in the
      last year of life and benefit from palliative care, the prognostic capability of the Surprise
      Question has been shown to be variable. What is unclear, is the extent to which a doctor
      should be &quot;surprised&quot; before a patient is suitable for palliative care, how consistently
      doctors respond to this question, and how the subsequent treatment decision relates to the SQ
      response.

      The study will recruit 600 General Practitioners (GPs) from 6 participating countries (100
      per country; UK, Germany, Switzerland, Italy, Belgium, the Netherlands). Each participant
      will asked to complete a series of 20 hypothetical patient summaries in an online task.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 25, 2019</start_date>
  <completion_date type="Actual">March 1, 2020</completion_date>
  <primary_completion_date type="Actual">March 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Probability estimate</measure>
    <time_frame>Participants will have up to 8 months (until the study closes) to provide an estimate for each vignette (n=20)</time_frame>
    <description>The continuous estimate of probability of dying within the next 12 months for the SQ (0-100%).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Surprise Question</measure>
    <time_frame>up to 8 months (until the study closes)Participants will have up to 8 months (until the study closes) to provide a response for each vignette (n=20)</time_frame>
    <description>Dichotomous response to the SQ (Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The alternative Surprise Question</measure>
    <time_frame>up to 8 months (until the study closes)Participants will have up to 8 months (until the study closes) to provide a response for each vignette (n=20)</time_frame>
    <description>Dichotomous response to the alternative SQ (Yes/No)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment options</measure>
    <time_frame>up to 8 months (until the study closes)Participants will have up to 8 months (until the study closes) to provide a response for each vignette (n=20)</time_frame>
    <description>The options for the course of action selected by the participants in each vignette</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">250</enrollment>
  <condition>Palliative Care</condition>
  <condition>Terminal Illness</condition>
  <arm_group>
    <arm_group_label>General Practitioners</arm_group_label>
    <description>Registered General Practitioners in one of the six participating countries.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Online study</intervention_name>
    <description>20 hypothetical patient summaries</description>
    <arm_group_label>General Practitioners</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        A convenience sample of registered General Practitioners (GPs) with a variety of years of
        experience and seniority across six European countries will be approached to participate
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Registered General Practitioner in one of the six participating countries

          -  Able to read and understand the language in which the questionnaire is presented to
             them

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick Stone, MA, MD, FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>University College, London</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Antwerp</name>
      <address>
        <city>Antwerp</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Mainz</name>
      <address>
        <city>Mainz</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Bologna</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radboud University Medical Centre</name>
      <address>
        <city>Nijmegen</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital of Bern</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marie Curie Palliative Care Research Department</name>
      <address>
        <city>London</city>
        <zip>W1W 7EJ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>https://bmcpalliatcare.biomedcentral.com/articles/10.1186/s12904-019-0413-x</url>
    <description>The Study Protocol</description>
  </link>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>September 25, 2018</study_first_submitted>
  <study_first_submitted_qc>October 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2018</study_first_posted>
  <last_update_submitted>March 25, 2020</last_update_submitted>
  <last_update_submitted_qc>March 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Surprise Question</keyword>
  <keyword>Prognostication</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 9, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/13/NCT03697213/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

